Literature DB >> 8897579

The treatment of renal osteodystrophy.

S P Rigden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8897579     DOI： 10.1007/s004670050184

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  13 in total

1.  Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol.

Authors:  S Lopez-Hilker; A S Dusso; N S Rapp; K J Martin; E Slatopolsky
Journal:  Am J Physiol       Date:  1990-09

2.  Serum intact parathyroid hormone and ionised calcium concentration in children with renal insufficiency.

Authors:  S E Ledermann; A Johnson; M J Dillon; R S Trompeter; T M Barratt
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

3.  Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure.

Authors:  E M Brown; R E Wilson; R C Eastman; J Pallotta; S P Marynick
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

4.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

5.  Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

Authors:  J Silver; J Russell; L M Sherwood
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Long-term suppression of hyperparathyroidism by phosphate binders in uremic children.

Authors:  K Tamanaha; R H Mak; S P Rigden; C Turner; K M Start; G B Haycock; C Chantler
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

7.  Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.

Authors:  R H Mak; C Turner; T Thompson; H Powell; G B Haycock; C Chantler
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-07

8.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11

9.  On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog.

Authors:  E Slatopolsky; S Caglar; J P Pennell; D D Taggart; J M Canterbury; E Reiss; N S Bricker
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

10.  Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.

Authors:  W G Goodman; J A Ramirez; T R Belin; Y Chon; B Gales; G V Segre; I B Salusky
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612
View more
  3 in total

1.  Parathyroid hormone and its fragments in children with chronic renal failure.

Authors:  Simon Waller; Anthony Reynolds; Deborah Ridout; Tom Cantor; Ping Gao; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2003-10-24       Impact factor: 3.714

2.  Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?

Authors:  Tuure T Saarinen; Pekka Arikoski; Christer Holmberg; Kai Rönnholm
Journal:  Pediatr Nephrol       Date:  2007-09-13       Impact factor: 3.714

3.  Catch-up growth with normal parathyroid hormone levels in chronic renal failure.

Authors:  Simon Waller; Sarah Ledermann; Richard Trompeter; William van't Hoff; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.